About us

Yourgene offers a comprehensive suite of non-invasive prenatal testing (NIPT) solutions, including a complete NGS workflow designed to provide laboratories with flexible, scalable testing and a broad clinical menu, tailored to their needs. In addition, we provide a clinical NIPT sample service through our Manchester Genomic Service Laboratory for healthcare professionals.

The IONA® test pioneered the NIPT screening landscape in 2015 as the first in-vitro diagnostic NIPT assay available on the market.

Supporting the wider reproductive lifecycle, we also offer a portfolio of PCR-based clinical screening assays, including tests for cystic fibrosis, aneuploidy analysis, pregnancy loss, male factor infertility, and thrombosis risk.

As part of our expanding Precision Medicine portfolio, our DPYD genotyping PCR assay supports safer chemotherapy regimes, by identifying patients at risk of severe fluoropyrimidine toxicity.

Early detection of DPD deficiency before starting 5-FU treatment enables clinicians to adjust chemotherapy dosing and avoid serious, potentially life-threatening adverse reactions.

Powered by Ranger® Technology, our portfolio of automated DNA size selection instruments delivers high-precision fragment selection and dynamic target enrichment across a wide range of clinical and research sequencing applications. Designed to support laboratories from low- to high-throughput workflows, Ranger® instruments provide an innovative solution for applications including NIPT, gene synthesis, CRISPR gene editing, and long-read sequencing.

Developed in close collaboration with PacBio, the LightBench® Discover is fully compatible with the PacBio Revio® and Vega™ platforms, making it ideally suited for enhancing long-read sequencing workflows.

The LightBench® Discover is an automated 3-in-1 electrophoresis system combining DNA size selection, fragment length analytics, and quantification in a single benchtop solution, removing the need for multiple instruments and simplifying laboratory workflows.